Rakesh Jhunjhunwala's portfolio stock has all buy ratings, but target below issue price - Economic Times

Despite the recent fall in shares of Star Health, market analysts are bullish on the counter with suggestions to buy the dip. However, their target prices are quite below the issue price of the stock.

New Delhi: One of the latest debutants from Rakesh Jhunjhunwala's portfolio, , is not in the pink of its health. The scrip settled 2 per cent lower at Rs 701.15 on BSE on Friday. It is down about 22… [+2891 chars]

full article...